论文部分内容阅读
目的分析奥拉西坦治疗高血压脑出血患者的临床疗效。方法 88例高血压脑出血患者,随机分为对照组与观察组,各44例。对照组给予常规治疗,观察组在常规治疗基础上加用奥拉西坦治疗,对比分析两组患者的临床治疗效果。结果观察组总有效率为90.9%,对照组为70.5%,观察组总有效率高于对照组(P<0.05);治疗前,两组患者简易精神状态检查表(MMSE)评分与Barthel指数比较,差异无统计学意义(P>0.05);治疗后,观察组MMSE评分、Barthel指数优于对照组(P<0.05)。结论奥拉西坦治疗高血压脑出血患者的临床疗效显著。
Objective To analyze the clinical efficacy of oxiracetam in patients with hypertensive intracerebral hemorrhage. Methods 88 patients with hypertensive cerebral hemorrhage were randomly divided into control group and observation group, 44 cases in each group. The control group was given routine treatment. The observation group was treated with oxiracetam on the basis of conventional treatment, and the clinical treatment effect was compared between the two groups. Results The total effective rate was 90.9% in the observation group and 70.5% in the control group, and the total effective rate in the observation group was higher than that in the control group (P <0.05). Before the treatment, MMSE score and Barthel index (P> 0.05). After treatment, MMSE score and Barthel index in the observation group were better than those in the control group (P <0.05). Conclusion The clinical efficacy of oxiracetam in patients with hypertensive intracerebral hemorrhage is significant.